Current Treatment Approaches to HCC with a Special Consideration to Transplantation

Table 1

Comparison of survival; Milan versus extended criteria.

Study	Number	Milan criteria	Extended criteria	5-year survival
				Milan	Extended
Yao et al. [18]	60	46	14	72%	72%
Herrero et al. [19]	61	49	12	79% entire cohort
Roayaie et al. [20]	31	0	31	N/A	55%
Kneteman et al. [21]	40	19	21	4-year survival
				87%	83%
Yao et al. [22]	168	130	38	80%	82%
Onaca et al. [23]	1152	1038	114	62%	54%
Cillo et al. [24]	100	60	40	3-year survival
				69%	85%
Mazzaferro et al. [25]	1556	444	1112	Up-to-seven
				73.3%	71.2%
				Exceeding up-to-seven
				73.3%	53.6%
Guiteau et al. [26]	445	363	82	72.9%	70.2%